By Steve Marriott on July 24, 2020
Spirit Health Group is seeking expressions of interest from individuals or organisations that can deliver expertise in Pharmaceutical Regulatory Affairs and who have specific experience overseeing the licencing of biosimilars.
We are especially interested in engaging with any individuals or organisations who have experience of licencing new products for the treatment of diabetes, although this is not a pre-requisite.
All interested parties should contact Dr Emma Richardson at email@example.com for further details and an initial discussion;
All formal submissions of quotations for work must be received by 5pm 14 August 2020.